Investor relations
Raising up to US$100M to build India's cancer vaccine platform
We are looking for partners who want to build lasting scientific and manufacturing capability in affordable cancer immunotherapy, for a market of more than 1.4 million new cancer patients in India every year.
- Round size
- Up to US$100M
- Sector
- Biotechnology · Immuno-oncology
- Use of funds
- R&D, process development, GMP facility, clinical trials
- Horizon
- 84-month plan with go/no-go milestone gates
Request access
Investor inquiry
Tell us about yourself and your investment interest. Our team will reply with next steps. These may include signing an NDA before we share confidential materials.
- Investor deck and executive summary
- Phase-wise budget and financial model
- Data room: team, IP, partnerships and audited financials